Farms.com Home   News

USDA announces Grassland Conservation Reserve Program signup for 2023

The United States Department of Agriculture (USDA) has announced the signup period for the Grassland Conservation Reserve Program (CRP) for 2023. The program, which runs through May 26, 2023, aims to support the conservation of grasslands and wildlife habitat by providing financial incentives to landowners who voluntarily enroll eligible land in the program. 

Through the program, landowners can receive payments for planting native grasses, forbs, and shrubs that provide food and habitat for a variety of wildlife species, including birds, mammals, and insects. By protecting and restoring grasslands, the program also helps to prevent soil erosion, reduce nutrient runoff, and improve water quality. 

According to USDA officials, the Grassland CRP has already been successful in preserving and enhancing more than two million acres of grasslands across the country. By continuing to invest in this program, they hope to protect even more critical wildlife habitat and contribute to the overall health and sustainability of our ecosystems. 

The Grassland Conservation Reserve Program offers a valuable opportunity for landowners to contribute to conservation efforts while also receiving financial support for their efforts. As the USDA continues to promote the importance of protecting our natural resources, programs like this will be crucial in ensuring a sustainable future for generations to come. 


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.